Medherent Ltd, developer of the TEPI© Patch drug delivery technology, has appointed John Burt as its new CEO
Verdel Instruments Ltd - a spin-out company of the University of Warwick UK – has developed new disruptive two-dimensional mass spectrometry (2DMS) technology and raised seed investment of over £230,000 from Longwall Ventures and Innovate UK.
Warwick University spinout, Spectra Analytics, has been awarded £1m by Innovate UK to improve Primary Care using AI
Medherant Limited, the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investment from Mercia Technologies PLC.
The Faculty of Social Sciences and Warwick Ventures celebrated the conclusion of the first-ever VIBE (Venture Into Business Engagement) programme; a newly created programme to help Social Sciences researchers engage with business.
Innovation to Commercialisation of University Research (ICURe) is designed to move ideas and innovation out of universities and into the marketplace, where they will have the greatest impact. If you are an Early Career Researcher and think your research might have commercial potential, find out how to apply here.
The Midlands Innovation group of eight universities, including Warwick, has launched its Commercialisation of Research Accelerator Programme, and is on target to deliver against its goals to support development of spin-out companies and attract investment and skills to the Midlands region.
Warwick University’s Engineering research and a University spin out company featured on The One Show on Monday 18 March.
Twelve new university spin-out companies are gearing up to present their ideas later this month at two showcase events in London and Birmingham.
Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has successfully completed two Phase I studies with its novel Ibuprofen TEPI® Patch.